Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check2 days agoChange DetectedA new publication citation was added to the Publications section describing long-term safety and efficacy of upadacitinib in Japanese RA patients. Several items in the Related Topics/Links area were removed, including MedlinePlus Genetics, a clinical study report synopsis, AbbVie-related links, and Helpful Links.SummaryDifference0.2%

- Check9 days agoChange DetectedRevision: v3.5.3 was added, replacing v3.5.2. This reflects an update to the page's versioning metadata rather than substantive content changes.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded a “Rheumatoid arthritis” related topics section, including links to MedlinePlus Genetics.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 in the page footer.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved the terms 'Rheumatoid arthritis' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded 'Rheumatoid arthritis' as a topic and added 'MedlinePlus Genetics' as a related topic to the page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.